FDA Import Refusal 799-7846309-8/11/1 — HOMELINX PHARMACY
The FDA refused shipment 799-7846309-8/11/1 from HOMELINX PHARMACY (Canada) on Mar 28, 2022. The refused product falls under Drugs and Biologics — ADALIMUMAB. Cited charge: 75
Refusal details
- Date
- Mar 28, 2022
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61YCB02 ADALIMUMAB
- Charges
- 75